American Research & Management Company’s Takeda Pharmaceutical TAK Stock Holding History

American Research & Management Company’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$26K	Hold	2,000	–	–	0.01%	238
2022 Q2	$28K	Hold	2,000	–	–	0.01%	232
2022 Q1	$29K	Hold	2,000	–	–	0.01%	236
2021 Q4	$27K	Hold	2,000	–	–	0.01%	244
2021 Q3	$33K	Hold	2,000	–	–	0.01%	228
2021 Q2	$34K	Hold	2,000	–	–	0.01%	234
2021 Q1	$37K	Hold	2,000	–	–	0.01%	212
2020 Q4	$36K	Hold	2,000	–	–	0.01%	218
2020 Q3	$36K	Hold	2,000	–	–	0.01%	200
2020 Q2	$36K	Hold	2,000	–	–	0.01%	205
2020 Q1	$30K	Buy	2,000 +1,940	+3,233%	+$35.2K	0.01%	201
2019 Q4	$1K	Buy	+60	New	+$1.15K	﹤0.01%	328
2019 Q2	–	Sell	-745	Closed	-$15K	–	372
2019 Q1	$15K	Buy	+745	New	+$15K	﹤0.01%	303

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

American Research & Management Company's TAK Position: Q3 2022 in Review

American Research & Management Company held its Takeda Pharmaceutical (TAK) position steady in Q3 2022 at 2,000 shares worth $26K. The position accounts for 0.01% of the portfolio, ranked #238.

American Research & Management Company first reported a position in TAK in Q1 2019 and has held it in 13 quarters since. The position peaked at $37K in Q1 2021. 276 funds tracked by Wall St. Rank hold TAK as of Q3 2022.

American Research & Management Company held 2,000 shares of Takeda Pharmaceutical worth $26K as of Q3 2022.
American Research & Management Company left its Takeda Pharmaceutical share count unchanged in Q3 2022.
Takeda Pharmaceutical made up 0.01% of American Research & Management Company's portfolio in Q3 2022, its #238 holding.
American Research & Management Company first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 13 quarters since.
American Research & Management Company's Takeda Pharmaceutical position peaked at $37K in Q1 2021.
276 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.